Oct 12, 2026
Bristol Myers experimental drugs show promise in late-stage lung disease and cancer trials
Bristol Myers Squibb reported positive results from late-stage trials of experimental drugs for treating a rare endocrine cancer and idiopathic pulmonary fibrosis, with the radiopharmaceutical therapy significantly delaying disease progression in gastrointestinal and pancreatic tumors.
3 sources
00